Insmed | Devedores Comerciais

Created with Highcharts 10.1.0Chart context menu23.6M28.2M33.4M38.7M43.9M49.2M53.8M
2022Q32023Q32024Q3


Trade Debtors Alterar Data
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Cytokinetics USD 16.65M 16.41M 2024-12
DBV Technologies USD 20.1M 553K 2024-09
Dynavax Technologies USD 46.91M 28.37M 2024-12
Gilead Sciences USD 4.42B 167M 2024-12
Insmed USD 52.01M 9.7M 2024-12
Novartis USD 7.56B 594M 2024-12
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Insmed Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.